Next, stay for the diabetes tech show-and-tell as Diana demonstrates the specs of the latest pumps and sensors
Figure 1 from Colhoun , et al, Nat Med 2024 Even if semaglutide saves lives, hearts, and kidneys, and FLOW is a global trial, implementation of the so-called fourth pillar remains a local challenge
Why the FDA Issued Warnings The FDA determined that companies marketing compounded retatrutide: Sold an unapproved new drug without FDA authorization Misbranded products by providing no adequate directions for safe use Improperly claimed compounding exemptions that do not apply to investigational substances In short, these products are not permitted for compounding or distribution under current federal law
Together, they are more effective than either alone
The real choice is a tradeoff between average weight-loss strength, price, side effects, availability, and what your doctor thinks fits your history
GLP-1 drugs can be life-changing for people with obesity or diabetes